Geneos Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.8K | Sell |
|
|||||
|
2025
Q2 | $842K | Sell |
|
|||||
|
2025
Q1 | $2.38M | Buy |
|
|||||
|
2024
Q4 | $585K | Sell |
|
|||||
|
2024
Q3 | $789K | Buy |
|
|||||
|
2024
Q2 | $34.7K | Buy |
|
|||||
|
2024
Q1 | $28.8K | Sell |
|
|||||
|
2023
Q4 | $34.2K | Sell |
|
|||||
|
2023
Q3 | $66.4K | Buy |
|
|||||
|
2023
Q2 | $48.2K | Buy |
|
|||||
|
2023
Q1 | $2.21K | Sell |
|
|||||
|
2022
Q4 | $36.7K | Hold |
|
|||||
|
2022
Q3 | $36K | Sell |
|
|||||
|
2022
Q2 | $127K | Hold |
|
|||||
|
2022
Q1 | $116K | Buy |
|
|||||
|
2021
Q4 | $71K | Buy |
|
|||||
|
2021
Q3 | $40K | Buy |
|
|||||
|
2021
Q2 | $44K | Sell |
|
|||||
|
2021
Q1 | $568K | Sell |
|
|||||
|
2020
Q4 | $605K | Buy |
|
|||||
|
2020
Q3 | $163K | Sell |
|
|||||
|
2020
Q2 | $259K | Buy |
|
|||||
|
2020
Q1 | $138K | Buy |
|
|||||
|
2019
Q4 | $118K | Hold |
|
|||||
|
2019
Q3 | $89K | Buy |
|
|||||
|
2019
Q2 | $96K | Sell |
|
|||||
|
2019
Q1 | $105K | Sell |
|
|||||
|
2018
Q4 | $96K | Hold |
|
|||||
|
2018
Q3 | $115K | Buy |
|
|||||
|
2018
Q2 | $96K | Sell |
|
|||||
|
2018
Q1 | $104K | Hold |
|
|||||
|
2017
Q4 | $95K | Sell |
|
|||||
|
2017
Q3 | $107K | Buy |
|
|||||
|
2017
Q2 | $32K | Hold |
|
|||||
|
2017
Q1 | $27K | Sell |
|
|||||
|
2016
Q4 | $20K | Hold |
|
|||||
|
2016
Q3 | $23K | Buy |
|
|||||
|
2016
Q2 | $22K | Hold |
|
|||||
|
2016
Q1 | $20K | Buy |
|